Improved Glycemic Control with Carbohydrate Counting for Adjustment of Fast-Acting Insulin Aspart vs. Insulin Aspart in Subjects with Type 1 Diabetes

被引：0
|
作者：
Philis-Tsimikas, Athena
Bode, Bruce W.
Franek, Edward
Rose, Ludger
Buchholtz, Kristine
Demissie, Marek
Pieber, Thomas R.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
997-P
引用
收藏
页码：A260 / A260
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of fast-acting insulin aspart are maintained over 52 weeks: Comparison with insulin aspart in onset 1
    Twigg, Stephen
    Mathieu, Chantal
    Bode, Bruce
    Franek, Edward
    Philis-Tsimikas, Athena
    Rose, Ludger
    Graungaard, Tina
    Osterskov, Anne Birk
    Russell-Jones, David
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 63 - 63
  • [32] Efficacy and safety of fast-acting insulin aspart are maintained over 52 weeks: comparison with insulin aspart in onset 1
    Mathieu, C.
    Bode, B.
    Franek, E.
    Philis-Tsimikas, A.
    Rose, L.
    Graungaard, T.
    Osterskov, A.
    Russell-Jones, D.
    DIABETOLOGIA, 2017, 60 : S314 - S314
  • [33] Glycaemic control with fast-acting insulin aspart according to dose adjustment method in type 1 diabetes: a post hoc analysis of onset 8
    Pieber, T. R.
    Buse, J.
    Rose, L.
    Gorst-Rasmussen, A.
    Boesgaard, T. W.
    Buchholtz, K.
    Mosenzon, O.
    DIABETOLOGIA, 2018, 61 : S398 - S399
  • [34] Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
    Ludger Rose
    Takashi Kadowaki
    Thomas R. Pieber
    Kristine Buchholtz
    Magnus Ekelund
    Anders Gorst-Rasmussen
    Athena Philis-Tsimikas
    Diabetes Therapy, 2019, 10 : 1029 - 1041
  • [35] Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
    Rose, Ludger
    Kadowaki, Takashi
    Pieber, Thomas R.
    Buchholtz, Kristine
    Ekelund, Magnus
    Gorst-Rasmussen, Anders
    Philis-Tsimikas, Athena
    DIABETES THERAPY, 2019, 10 (03) : 1029 - 1041
  • [36] The Impact of Baseline BMI and HbA1c on Glycemic Control after Treatment with Fast-Acting Insulin Aspart in Individuals with Type 2 Diabetes
    Bowering, Keith
    Bode, Bruce W.
    Harris, Stewart B.
    Piletic, Milivoj
    Babu, Vinay
    Dethlefsen, Claus
    Rodbard, Helena W.
    DIABETES, 2017, 66 : A253 - A253
  • [37] Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial
    Buse, John B.
    Carlson, Anders L.
    Komatsu, Mitsuhisa
    Mosenzon, Ofri
    Rose, Ludger
    Liang, Bo
    Buchholtz, Kristine
    Horio, Hiroshi
    Kadowaki, Takashi
    DIABETES OBESITY & METABOLISM, 2018, 20 (12): : 2885 - 2893
  • [38] Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective
    Senior, Peter
    Hramiak, Irene
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (07) : 515 - 523
  • [39] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart in combination with insulin degludec in Japanese adults with type 1 diabetes: a subgroup analysis of the randomized onset 8 trial
    Komatsu, Mitsuhisa
    Ekelund, Magnus
    Horio, Hiroshi
    Kadowaki, Takashi
    ENDOCRINE JOURNAL, 2021, 68 (04) : 429 - 440
  • [40] Use of fast-acting insulin aspart in insulin pump therapy in clinical practice
    Evans, Mark
    Ceriello, Antonio
    Danne, Thomas
    De Block, Christophe
    DeVries, J. Hans
    Lind, Marcus
    Mathieu, Chantal
    Norgaard, Kirsten
    Renard, Eric
    Wilmot, Emma G.
    DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2039 - 2047
12345